Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 288-297
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.288
Table 2 Patient comorbidities and management
VariableAll (58362)Teaching (30382)Non-teaching (27979)
Elixhauser comorbiditiesa
02568 (4.4)1398 (4.6)1175 (4.2)
18929 (15.3)4679 (15.4)4281 (15.3)
214707 (25.2)7565 (24.9)7135 (25.5)
≥ 332157 (55.1)16740 (55.1)15388 (55.0)
Liver comorbidities
Alcoholic cirrhosis30232 (51.8)16102 (53.0)14157 (50.6)
Ascites19551 (33.5)10998 (36.2)8534 (30.5)
Hepatic encephalopathy9280 (15.9)5286 (17.4)4001 (14.3)
SBP1109 (1.9)760 (2.5)336 (1.2)
Hepatorenal syndrome1868 (3.2)1276 (4.2)616 (2.2)
Coagulopathya27255 (46.7)14340 (47.2)12870 (46.0)
Hepatocellular carcinoma2101 (3.6)1398 (4.6)699 (2.5)
Management
Blood transfusion36184 (62.0)18199 (59.9)17963 (64.2)
Balloon tamponade525 (0.9)365 (1.2)168 (0.6)
Portosystemic shunt3268 (5.6)2400 (7.9)867 (3.1)